金石亚药(300434) - 2025 Q2 - 季度业绩预告

Sichuan Jinshi Asia Pharmaceutical Co., Ltd. 2025 Semi-Annual Performance Forecast Current Period Performance Forecast The company anticipates substantial H1 2025 performance growth, with net profit attributable to shareholders increasing by 50.04% to 85.24% and non-recurring adjusted net profit by 31.28% to 68.55% 2025 Semi-Annual Performance Forecast Key Data | Metric | Current Period (2025 H1 Est.) | Prior Period (2024 H1) | Year-on-Year Growth | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders (Million Yuan) | 58.82 - 72.62 | 39.20 | 50.04% - 85.24% | | Net Profit After Non-Recurring Items (Million Yuan) | 48.62 - 62.42 | 37.04 | 31.28% - 68.55% | Communication with Accounting Firm The company explicitly states that the financial data presented in this performance forecast remains unaudited by an accounting firm - The data in this performance forecast is unaudited by an accounting firm[3] Explanation of Performance Changes Performance growth is attributed to optimized budget and cost control, successful commercialization of new materials and machinery R&D projects, and a positive impact from non-recurring gains and losses - The company achieved a reduction in period expenses through measures such as budget optimization and cost control, fostering stable business development[4] - The new materials and machinery business segment saw improved revenue and gross profit due to the commercialization of certain prior R&D projects[4] - During the reporting period, non-recurring gains and losses are estimated to have a positive impact of approximately 10.19 million yuan on net profit[4] Other Relevant Information This performance forecast represents preliminary financial department estimates, with final accurate data to be disclosed in the 2025 semi-annual report, cautioning investors about associated risks - This performance forecast is a preliminary estimate by the company's finance department, with specific financial data subject to the 2025 semi-annual report[5] Reference Documents The board of directors' explanation regarding the 2025 semi-annual performance forecast is designated as a reference document in the announcement - The reference document is the board of directors' explanation regarding the 2025 semi-annual performance forecast[6]